Vascular effects of environmental oestrogens: implications for reproductive and vascular health

被引:28
作者
Dubey, RK
Rosselli, M
Imthurn, B
Keller, PJ
Jackson, EK
机构
[1] Univ Pittsburgh, Med Ctr, Dept Med, Ctr Clin Pharmacol, Pittsburgh, PA 15213 USA
[2] Univ Zurich Hosp, Dept Obstet & Gynecol, Clin Endocrinol, CH-8091 Zurich, Switzerland
关键词
angiogenesis; endothelial cells; environmental oestrogens; smooth muscle cells; vascular remodelling;
D O I
10.1093/humupd/6.4.351
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Environmental oestrogens are defined as xenobiotics structurally resembling oestrogen, and are divided into two broad categories, xeno-oestrogens and phyto-oestrogens, Environmental oestrogens may contribute importantly to the increased incidence of reproductive disorders in the modern environment. Although the mechanisms by which environmental oestrogens induce their deleterious effects on the reproductive system remain poorly defined, it is likely that the vascular effects of these compounds play a critical role, In this regard, oestradiol strongly regulates both angiogenesis and vascular remodelling by influencing the growth and function of vascular endothelial cells (EC) and smooth muscle cells (SMC). Since blood vessels, by undergoing angiogenesis, vascular regression and vascular remodelling, actively participate in the normal functioning of reproductive organs, environmental oestrogens-by mimicking or antagonizing the vascular effects of oestradiol-may induce abnormalities in vascular function and structure leading to reproductive disorders such as pre-eclampsia, endometriosis, impaired follicular development, inefficient implantation, impotence and infertility. The purpose of the present review is to summarize the evidence regarding the vascular effects of xeno-oestrogens and phyto-oestrogens and to discuss the implications for these effects on the reproductive system.
引用
收藏
页码:351 / 363
页数:13
相关论文
共 139 条
[41]   CERVICAL VASCULAR MALFORMATION AS A CAUSE OF ANTEPARTUM AND INTRAPARTUM BLEEDING IN 3 DIETHYLSTILBESTROL-EXPOSED PROGENY [J].
FOLLEN, MM ;
FOX, HE ;
LEVINE, RU .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (08) :890-891
[42]   GENISTEIN, A DIETARY-DERIVED INHIBITOR OF INVITRO ANGIOGENESIS [J].
FOTSIS, T ;
PEPPER, M ;
ADLERCREUTZ, H ;
FLEISCHMANN, G ;
HASE, T ;
MONTESANO, R ;
SCHWEIGERER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2690-2694
[43]  
Goede V, 1998, LAB INVEST, V78, P1385
[44]  
Goodger Anne M., 1995, Microcirculation (New York), V2, P329, DOI 10.3109/10739689509148277
[45]   IN-UTERO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) ALTERS REPRODUCTIVE MORPHOLOGY AND FUNCTION IN FEMALE RAT OFFSPRING [J].
GRAY, LE ;
OSTBY, JS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (02) :285-294
[46]   Postmenopausal estrogen and progestin use and the risk of cardiovascular disease [J].
Grodstein, F ;
Stampfer, MJ ;
Manson, JE ;
Colditz, GA ;
Willett, WC ;
Rosner, B ;
Speizer, FE ;
Hennekens, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07) :453-461
[47]   Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro [J].
Grosskreutz, CL ;
Anand-Apte, B ;
Dupláa, C ;
Quinn, TP ;
Terman, BI ;
Zetter, B ;
D'Amore, PA .
MICROVASCULAR RESEARCH, 1999, 58 (02) :128-136
[48]   Estrogen receptor beta - Getting in on the action? [J].
Gustafsson, JA .
NATURE MEDICINE, 1997, 3 (05) :493-494
[49]   Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study [J].
Guzick, DS ;
Talbott, EO ;
SuttonTyrrell, K ;
Herzog, HC ;
Kuller, LH ;
Wolfson, SK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) :1224-1229
[50]  
Haller H, 1998, LANCET, V351, P945